Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merck KGaA (GB:0O14)
LSE:0O14
Merck KGaA (0O14) Share Price & Analysis
7 Followers
0O14 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€134.35 - €176.20
Previous Close€157.94
Volume63.21K
Average Volume (3M)92.31K
Market Cap
€69.35B
Enterprise Value€78.18B
Total Cash (Recent Filing)€1.64B
Total Debt (Recent Filing)€10.40B
Price to Earnings (P/E)25.2
Beta0.77
Next Earnings
Aug 01, 2024EPS Estimate
€1.96Last Dividend Ex-Date
Apr 29, 2024Dividend Yield1.43%
Share Statistics
EPS (TTM)6.26
Shares Outstanding129,242,250
10 Day Avg. Volume43,595
30 Day Avg. Volume92,312
Standard Deviation0.06
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€185.00Price Target Upside17.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Merck KGaA News
PremiumPre-Earnings
Is 0O14 a Buy, Before Earnings?
PremiumPre-Earnings
Merck KGaA (0O14) Q4 Earnings Cheat Sheet
PremiumGlobal Markets
Do Not Miss These DAX 40 Stocks’ Earnings
PremiumPre-Earnings
Is 0O14 a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMerck KGaA reported results that were broadly in line on revenue, and a 6%-7% beat on EBITDA vs forecasts.
Growth PotentialDouble-digit growth in 2025 is anticipated, driven by the recovery of Life Science and Semiconductors in the Electronics division.
Product DevelopmentSeveral products have the potential to be first-in-class or best-in-class, with promising results reported so far.
Bears Say
Financial PerformanceQ1 saw a -12.6% organic decline, driven by reductions across all business units.
Research And DevelopmentThe failure of the Xevinapant study has led to the halting of all its development, raising concerns about the company's R&D direction.
Sales PerformanceThe company's Life Science unit's revenue came in significantly below estimates, falling short by 9% against internal targets and 5% against consensus estimates.
---
0O14 FAQ
What was Merck KGaA’s price range in the past 12 months?
Merck KGaA lowest share price was €134.35 and its highest was €176.20 in the past 12 months.
What is Merck KGaA’s market cap?
Currently, no data Available
When is Merck KGaA’s upcoming earnings report date?
Merck KGaA’s upcoming earnings report date is Aug 01, 2024 which is in 5 days.
How were Merck KGaA’s earnings last quarter?
Merck KGaA released its earnings results on May 15, 2024. The company reported €2.06 earnings per share for the quarter, beating the consensus estimate of €1.881 by €0.179.
Is Merck KGaA overvalued?
According to Wall Street analysts Merck KGaA’s price is currently Undervalued.
Does Merck KGaA pay dividends?
Merck KGaA pays a Annually dividend of €2.2 which represents an annual dividend yield of 1.43%. See more information on Merck KGaA dividends here
What is Merck KGaA’s EPS estimate?
Merck KGaA’s EPS estimate is €1.96.
How many shares outstanding does Merck KGaA have?
Merck KGaA has 129,242,250 shares outstanding.
What happened to Merck KGaA’s price movement after its last earnings report?
Merck KGaA reported an EPS of €2.06 in its last earnings report, beating expectations of €1.881. Following the earnings report the stock price went up 4.786%.
Which hedge fund is a major shareholder of Merck KGaA?
Currently, no hedge funds are holding shares in GB:0O14
---
Merck KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€185.00 (17.13% Upside)
€185.00 (17.13% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.52%
12-Months-Change
Fundamentals
Return on Equity
10.05%
Trailing 12-Months
Asset Growth
1.78%
Trailing 12-Months
Company Description
Merck KGaA
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
---
0O14 Stock 12 Month Forecast
Average Price Target
€185.00
▲(17.13% Upside)
Technical Analysis
Best Analysts Covering 0O14
1 Year
1 Year Success Rate
20/26 ratings generated profit
1 Year Average Return
+16.17%
reiterated a buy rating 2 months ago
Copying Peter Spengler's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +16.17% per trade.
---